A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors

Clinical trial NCT07110883 · RECRUITING

Trial details

NCT number: NCT07110883
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-08-15
Primary completion: 2026-10-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.